Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure that patients continue paying nothing at drugstores or clinics.
Stephane Bancel told the Senate Committee on Health, Education, Labor and Pensions that the drugmaker will charge a list price of around $130 per dose for the vaccine in the U.S.That price is expected to go into effect later this year. Until now, the federal government had been Moderna’s lone U.S. customer, buying doses in bulk to make sure that people weren’t charged anything.
The hike will hit government payers like Medicaid and cost taxpayers, Sanders said as he pressed Bancel to reconsider the price. He also that Moderna will have to make more doses than it anticipates using to ensure enough is available. The company will then have to eat the cost of unused doses, something the government has done.Sanders later asked Bancel if Moderna was prepared to negotiate the price with Medicare, Medicaid and other agencies. Bancel replied that Moderna was “having discussions with all the different customers.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing WednesdayModerna’s CEO defended the company’s plan to quadruple the price of its COVID-19 vaccine to $130, similar to what Pfizer is predicted to price its vaccine. The U.S. government paid about $30 per dose from Moderna.
Leer más »
LIVE: Moderna CEO Stéphane Bancel testifies on potential Covid vaccine price hike — 3/22/23The U.S. Senate Committee on Health, Education, Labor and Pension holds a hearing on Moderna's potential price increase of the Covid-19 vaccine. Witnesses in...
Leer más »
Watch live: Moderna CEO Stephane Bancel testifies before Senate on Covid vaccine price hikeThe Boston biotech company plans to charge $130 per dose once the vaccination program moves to the private market as early as this fall.
Leer más »
Moderna CEO defends COVID vaccine price hike, citing pivot to endemic phaseModerna is hiking the price of its COVID-19 shot because it faces “increased complexity and risk” as the pandemic stabilizes and the life-saving vaccine pivots from a government-funded product to a commercial one, CEO Stephane Bancel told Congress Wednesday in a Senate hearing on what taxpayers are owed after they support critical medicine.
Leer más »